MitoQ, a Mitochondria-Targeted Antioxidant, Delays Disease Progression and Alleviates Pathogenesis in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis
Biochimica et Biophysica Acta - Molecular Basis of Disease - Netherlands
doi 10.1016/j.bbadis.2013.09.005
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2013
Authors
Publisher
Elsevier BV